A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -16.70% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -48.17%. Over the past 30 days, the price of MRVI has leaped by -21.32%. And in the last five days, it has fallen by -23.70%.
Maravai LifeSciences Holdings Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $11.56 on 05/17/24, while the lowest value for the same period was recorded at $4.28 on 11/18/24.
52-week price history of MRVI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Maravai LifeSciences Holdings Inc’s current trading price is -60.71% away from its 52-week high, while its distance from the 52-week low is 6.20%. The stock’s price range during this period has varied between$4.28 and $11.56. The Maravai LifeSciences Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.29 million for the day, a figure considerably higher than their average daily volume of 1.94 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Maravai LifeSciences Holdings Inc (MRVI) has experienced a quarterly decline of -43.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.15B and boasts a workforce of 650 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.00, with a change in price of -4.45. Similarly, Maravai LifeSciences Holdings Inc recorded 1,773,649 in trading volume during the last 100 days, posting a change of -49.50%.
MRVI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRVI stands at 1.63. Similarly, the long-term debt-to-equity ratio is also 1.59.
MRVI Stock Stochastic Average
Maravai LifeSciences Holdings Inc’s raw stochastic average for the past 50 days is presently 6.60%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 1.76%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.66% and 40.09%, respectively.
